objective(s) some properties of neuraminidase produced by pseudomonas aeruginosa pao1 growth in a defined medium (bhi) were examined and evaluated for its features. materials and methods the obtained supernatant enzyme of p. aeruginosa pao1 cultures was used in a sensitive fluorometric assay by using 2'-(4-methylumbelliferyl) a-d-n acetylneuraminic acid as substrate. as hydrolyzing mun wit...

In this cross-sectional survey conducted from August 1, 2009 to January 31, 2010, 400 women with primary infertility attending Valiasr reproductive health research center in Tehran, Iran, were interviewed using the Revised Conflict Tactics Scales questionnaire (CTS2). This instrument was developed to investigate the presence domestic violence. A total of 247 women (61.8%) reported having experi...

The purpose of this study was to describe antecedents and characteristics of same level fall injuries. Fall incidents and costs were compiled from the Bureau of Labor Statistics and other sources from 2006–2010. This study indicated that over 29% of ‘fall on same level’ injuries resulted in 31 or more workdays lost. The major source of injury was ‘floors, walkways or ground surfaces’, and the m...

The CG56 domain generates assembly code for the Motorola 56001 processor. Chapter 13 describes the features common to all code generation domains. The basic principles of writing code generation stars are explained in section 13.2. You will find explanations for codeblocks, macros, and attributes there. This chapter explains features specific to the CG56 domain. Refer to the CG56 chapter in the...

It is known that extremal doubly-even self-dual codes of length n ≡ 8 or 0 (mod 24) yield 3or 5-designs respectively. In this paper, by using the generator matrices of bordered double circulant doubly-even self-dual codes, we give 3-(n, k; m)-SEEDs with (n, k, m) ∈ {(32, 8, 5), (56, 12, 9), (56, 16, 9), (56, 24, 9), (80, 16, 52)}. With the aid of computer, we obtain 22 generator matrices of bor...

Intervention Patients were allocated to dextroamphetamine sulphate, 15 mg for 28 days then doubled to 30 mg for 56 days {n=47}†; dextroamphetamine sulphate, 30 mg for 28 days and then doubled to 60 mg for 56 days {n=46}†; or to placebo {n=35}†. Patients received dextroamphetamine sulphate sustained release regimen once within 2 hours of awakening, and once 6 hours later. Dosing was supervised i...